Correlation Between Cingulate and Allarity Therapeutics
Can any of the company-specific risk be diversified away by investing in both Cingulate and Allarity Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cingulate and Allarity Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cingulate and Allarity Therapeutics, you can compare the effects of market volatilities on Cingulate and Allarity Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cingulate with a short position of Allarity Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cingulate and Allarity Therapeutics.
Diversification Opportunities for Cingulate and Allarity Therapeutics
0.59 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Cingulate and Allarity is 0.59. Overlapping area represents the amount of risk that can be diversified away by holding Cingulate and Allarity Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Allarity Therapeutics and Cingulate is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cingulate are associated (or correlated) with Allarity Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Allarity Therapeutics has no effect on the direction of Cingulate i.e., Cingulate and Allarity Therapeutics go up and down completely randomly.
Pair Corralation between Cingulate and Allarity Therapeutics
Given the investment horizon of 90 days Cingulate is expected to generate 0.62 times more return on investment than Allarity Therapeutics. However, Cingulate is 1.61 times less risky than Allarity Therapeutics. It trades about 0.01 of its potential returns per unit of risk. Allarity Therapeutics is currently generating about -0.04 per unit of risk. If you would invest 373.00 in Cingulate on August 30, 2025 and sell it today you would lose (6.00) from holding Cingulate or give up 1.61% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cingulate vs. Allarity Therapeutics
Performance |
| Timeline |
| Cingulate |
| Allarity Therapeutics |
Cingulate and Allarity Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cingulate and Allarity Therapeutics
The main advantage of trading using opposite Cingulate and Allarity Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cingulate position performs unexpectedly, Allarity Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Allarity Therapeutics will offset losses from the drop in Allarity Therapeutics' long position.| Cingulate vs. Brandywine Realty Trust | Cingulate vs. LATAM Airlines Group | Cingulate vs. Nascent Wine | Cingulate vs. United Utilities Group |
| Allarity Therapeutics vs. Bangkok Dusit Medical | Allarity Therapeutics vs. Sabra Healthcare REIT | Allarity Therapeutics vs. Akso Health Group | Allarity Therapeutics vs. Aperture Health |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |